Guided Therapeutics GTHP Cash Flow Statement (2010-2026)

OTC GTHP
$0.20 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT
Reported Financials

Guided Therapeutics Quarterly Cash Flow Statement

Periods 63 quarters
Latest Jun 2026

Guided Therapeutics reported cash from operations of -$0.32M and free cash flow of -$0.32M for the quarter ended Jun 2026, down 88.8% year over year. This cash flow statement covers 63 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
0.07M-0.44M-0.51M-0.93M-1.10M-1.81M-0.87M-1.56M-0.68M-0.39M-0.40M-0.71M-0.65M-0.65M-0.43M-0.81M-0.74M-1.22M-0.50M-0.60M
Depreciation and DepletionDep. & Depletion
2.32M
Share-based CompensationStock Comp.
0.06M0.05M0.04M0.04M0.04M0.38M2.34M2.34M2.34M-0.05M2.34M2.34M2.88M-0.01M2.88M3.07M2.83M0.03M3.45M3.45M
Asset Writedowns and ImpairmentWritedown
-0.00M0.00M0.00M
Non-cash ItemsNon-Cash Items
Cash from OperationsCash from Ops.
-0.74M0.16M-0.18M-0.35M-0.61M-0.34M-0.50M-0.44M-0.47M-0.34M-0.10M-0.21M-0.47M-0.33M-0.33M-0.17M-0.28M-0.29M-0.62M-0.32M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.06M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.03M0.03M0.02M0.02M
Amortization of Deferred ChargesAmort. Deferred Charges
0.01M0.07M0.04M0.04M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.02M0.02M0.04M0.07M0.07M0.05M0.06M0.05M0.04M
Depreciation & Amortization (CF)Dep. & Amort.
2.32M
Change in Working Capital
Change in ReceivablesChange Receivables
0.00M0.02M0.01M0.01M-0.03M-0.00M0.00M-0.00M-0.00M-0.00M-0.00M0.01M
Change in InventoryChange Inventory
0.04M-0.05M0.00M0.00M0.02M0.03M-0.04M0.06M0.07M-0.01M0.00M-0.00M-0.04M-0.01M-0.14M0.02M0.03M
Change in Account PayablesChange Payables
Change in Accured ExpensesChange Accured Exp.
-0.45M0.57M0.08M-0.01M-0.08M0.13M-0.15M-0.02M0.04M0.17M-0.08M0.40M0.07M0.16M0.11M0.22M0.20M0.83M-0.10M0.19M
Other Working Capital ChangesOther WC Changes
-0.11M0.38M-0.08M0.39M-0.65M0.69M0.02M-0.06M-0.03M-0.03M-0.01M-0.04M-0.03M-0.04M-0.11M-0.04M-0.03M-0.03M-0.02M-0.06M
Investing Activities
Capital ExpendituresCapex
0.03M0.01M0.02M-0.00M0.00M
Cash from Investing ActivitiesCash from Investing
-0.01M-0.00M-0.01M-0.00M
Financing Activities
Other financing activitiesOther financing
-1.69M-0.06M0.36M0.13M0.04M0.20M0.24M0.30M0.54M0.26M0.98M
Cash from Financing ActivitiesCash from Financing
0.36M-0.05M0.28M0.09M2.86M-0.04M0.02M-0.04M-0.15M0.20M-0.05M0.04M0.39M0.53M0.06M0.24M0.18M0.27M0.92M-0.04M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
1.02M1.02M0.55M0.62M
Net Equity Issued and RepurchasedNet Equity Issued
-0.12M1.40M-0.00M0.54M0.20M
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
0.12M-0.05M0.12M
Additional items
Change in Cash
-0.38M0.10M0.08M-0.28M2.25M-0.38M-0.48M-0.48M-0.63M-0.14M-0.15M-0.17M-0.08M0.19M-0.27M0.07M-0.10M-0.02M0.31M-0.36M
Free Cash FlowFCF
-0.74M0.12M-0.19M-0.37M-0.61M-0.34M-0.50M-0.44M-0.47M-0.34M-0.10M-0.21M-0.47M-0.33M-0.33M-0.17M-0.28M-0.29M-0.62M-0.32M
Net Cash FlowNCF
-0.38M0.10M0.08M-0.26M2.25M-0.38M-0.48M-0.48M-0.63M-0.14M-0.15M-0.17M-0.08M0.19M-0.27M0.07M-0.10M-0.02M0.31M-0.36M